Results 231 to 240 of about 231,845 (277)

NLRC5-Deficient Macrophages Promote a Tumor-Permissive Phenotype via AXL- and MERTK-Mediated Efferocytosis. [PDF]

FASEB J
Haile SA, Gatta A, Colon N, Philpott DJ, Kufer TA, Ying L, Tong D, Ferrero RL.   +7 more
europepmc   +1 more source

Abstracts of 14th International Symposium on Hodgkin Lymphoma

HemaSphere, Volume 10, Issue S2, October 2026.
wiley   +1 more source

Angioimmunoblastic T-cell lymphoma with secondary hemophagocytic lymphohistiocytosis initially misdiagnosed as classical Hodgkin lymphoma: A case report. [PDF]

Medicine (Baltimore)
Li R, Chen Y, Liu X, Gao Y, Zhu N, Deng C, Li Y.   +6 more
europepmc   +1 more source

Inflammatory pseudotumor-like follicular dendritic cell sarcoma of the spleen: A diagnostic challenge with imaging-pathologic correlation. [PDF]

Radiol Case Rep
Cheng L, Wu S, Hu J.
europepmc   +1 more source

Primary splenic lymphoma - non-Hodgkin lymphoma

, 2013
openaire   +1 more source

Primary splenic lymphoma (marginal zone lymphoma)

, 2012
openaire   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Splenic marginal zone lymphoma

Blood Reviews, 2005
Splenic marginal zone lymphoma (SMZL) is an indolent B cell malignancy usually involving spleen, bone marrow and blood. The disease presents as an incidental finding or with symptoms of splenic enlargement or anaemia. Diagnosis is based on a combination of lymphocyte morphology, immunophenotype and marrow and /or splenic histology.
David Oscier, Roger Owen
exaly   +3 more sources